5WK-21673-59041
3 vaccinations
1 coded response
6 check-ins
1 free-text entry
1 call case
- Sex
- Female
- Age at first dose
- 0-4
- ZIP prefix
- 535 / WI
- Registered
- 2022-10-15
- Relationship
- Child or adolescent in my care
- Guardian
- 92P-10646-41214
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2022-07-07
Dose 1 — Pfizer-BioNTech
-
2022-07-28
Dose 2 — Pfizer-BioNTech
-
2022-09-23
Dose 3 — Pfizer-BioNTech
-
2022-10-15
Registered in v-safe
- 2022-10-15
- 2022-10-21
- 2022-10-28
- 2022-11-04
-
2022-12-23
Survey response — 3 months, dose 3, under 3MedDRA: Pre-existing disease — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Chronic sinusitisMedDRA releases: 2024-11 · check-in free text available
-
2022-12-23
Report sent to call center — 3 months, dose 3, under 3Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
-
2022-12-27
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
- 2023-03-24
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2022-07-07 | Pfizer-BioNTech | No |
| 2 | 2022-07-28 | Pfizer-BioNTech | No |
| 3 | 2022-09-23 | Pfizer-BioNTech | No |
Call center
1 call center case
1 successful
Free text
Release 12 (Under 3) — 3 months, dose 3, under 3
Symptoms: Chronic sinusitis
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Pre-existing disease | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release